Menu

Calmare Therapeutics Incorporated CTTC

Full chart Compare
Set alert

Price alert · CTTC

All alert types
0.00 0.00

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue → Gross Profit: $851.59KGross Profit → Expenses: $851.59KRevenue → Cost of Revenue: $317.29KExpenses → Selling, General & Admin: $3.25MExpenses → Interest Expense: $1.43MNet Loss → Expenses: $3.83MGross Profit$851.59KNet Loss$3.83MCost of Revenue$317.29KExpenses$4.68MSelling, General & Admin$3.25MInterest Expense$1.43MRevenue$1.17M

Latest period ending Dec 31, 2016 · select a line to chart its full history

CTTC annual income statement
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012
1.17M995.52K1.16M771.87K1.07M
851.59K715.84K722.97K499.13K703.30K
-2.39M-2.70M-2.23M-2.52M-2.87M
-3.83M-3.68M-3.41M-2.67M-3.00M
-0.13-0.13-0.15-0.16-0.20
CTTC annual balance sheet
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012
12.55K49.80K5.75K57.01K74.32K
3.88M4.21M4.43M4.57M4.77M
17.70M14.62M12.17M10.51M8.80M
5.54M3.85M2.59M2.49M1.53M
-13.81M-10.41M-7.74M-5.94M-4.03M
CTTC annual cash flow
Fiscal yearFY 2016 Dec 31, 2016FY 2015 Dec 31, 2015FY 2014 Dec 31, 2014FY 2013 Dec 31, 2013FY 2012 Dec 31, 2012
-1.24M-1.53M-1.06M-1.57M-1.37M
1.20M1.58M1.06M1.55M1.44M
-37.25K44.06K-51.26K-17.31K45.84K